BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26744895)

  • 1. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome.
    Fiot E; Zenaty D; Boizeau P; Haigneré J; Dos Santos S; Léger J;
    Eur J Endocrinol; 2016 Mar; 174(3):281-8. PubMed ID: 26744895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental origin of the X-chromosome does not influence growth hormone treatment effect in Turner syndrome.
    Devernay M; Bolca D; Kerdjana L; Aboura A; Gérard B; Tabet AC; Benzacken B; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1241-8. PubMed ID: 22593588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood.
    Fiot E; Zénaty D; Boizeau P; Haignere J; Dos Santos S; Léger J;
    Eur J Endocrinol; 2019 Jun; 180(6):397-406. PubMed ID: 30991358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.
    Hamelin CE; Anglin G; Quigley CA; Deal CL
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3002-10. PubMed ID: 16757526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of parental origin of the X chromosome on physical phenotypes and GH responsiveness of patients with Turner syndrome.
    Ko JM; Kim JM; Kim GH; Lee BH; Yoo HW
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):66-71. PubMed ID: 20148908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
    Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
    Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Turner syndrome with an X;Y translocation mosaicism: implications for genetic counseling.
    Portnoï MF; Chantot-Bastaraud S; Christin-Maitre S; Carbonne B; Beaujard MP; Keren B; Lévy J; Dommergues M; Cabrol S; Hyon C; Siffroi JP
    Eur J Med Genet; 2012 Nov; 55(11):635-40. PubMed ID: 22809487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
    Ranke MB; Schweizer R; Martin DD; Ehehalt S; Schwarze CP; Serra F; Binder G
    Horm Res Paediatr; 2012; 77(4):214-21. PubMed ID: 22433161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome.
    Stoklasova J; Zapletalova J; Frysak Z; Hana V; Cap J; Pavlikova M; Soucek O; Lebl J
    J Pediatr Endocrinol Metab; 2019 May; 32(5):479-488. PubMed ID: 31075085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body proportions in patients with Turner syndrome on growth hormone treatment.
    Al ADK; Şükür NM; Özturan EK; Öztürk AP; Poyrazoğlu Ş; Baş F; Darendeliler FF
    Turk J Med Sci; 2023 Apr; 53(2):518-525. PubMed ID: 37476877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.
    Soriano-Guillen L; Coste J; Ecosse E; Léger J; Tauber M; Cabrol S; Nicolino M; Brauner R; Chaussain JL; Carel JC
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5197-204. PubMed ID: 15998771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the SHOX gene in the pathophysiology of Turner syndrome.
    Oliveira CS; Alves C
    Endocrinol Nutr; 2011 Oct; 58(8):433-42. PubMed ID: 21925981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult height in girls with Turner syndrome treated from before 6 years of age with a fixed per kilogram GH dose.
    Wasniewska M; Aversa T; Mazzanti L; Guarneri MP; Matarazzo P; De Luca F; Lombardo F; Messina MF; Valenzise M
    Eur J Endocrinol; 2013 Oct; 169(4):439-43. PubMed ID: 23904278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final Adult Height after Growth Hormone Treatment in Patients with Turner Syndrome.
    Ahn JM; Suh JH; Kwon AR; Chae HW; Kim HS
    Horm Res Paediatr; 2019; 91(6):373-379. PubMed ID: 31480041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.